In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.
What the Global Fund gave us was 17 years of scaling up lifesaving HIV and TB treatment and pooling volumes in order to negotiate lower prices that are transparent. What the Global Fund gave us was setting a standard of quality for HIV and TB medicines, requiring approval from WHO ... read more
MSF Press Release UNAIDS update: High ongoing AIDS mortality reminds us that the fight against HIV is far from over Brussels / Geneva / Johannesburg, 16 July 2019.770 000 people died of HIV worldwide in 2018. These are disturbing figures in the UNAIDS 2019 report released today in Eshowe, South ... read more
Diploma in Public Health (DPH) is an course in public health sciences. The duration of the course is of 1 year inclusive of Industrial visits, research projects and internship. The candidate during and after the training should be able to implement the knowledge, skills & advances of public health for ... read more
Please find below a press release from MSF calling out Gilead’s failure to deliver on the promise to provide liposomal amphotericin B (L-AmB), a key drug to treat cryptococcal meningitis, at a supposed ‘no profit’ price of $16.25/vial in 116 low and middle-income countries. Gilead Sciences fails on promise to ... read more
Malawi-Liverpool-Wellcome Trust Clinical Research ProgrammeWork Locations
Ministry of Health, ZambiaWork Locations
General HospitalWork Locations